Physical review. ENeurosciencePeer-reviewed journal article
Boundary homogenization and numerical modeling of solute transport across the blood-brain barrier
- Citations
- 1
- FWCI
- 0.36
- Field percentile
- top 37%
Abstract
Effective clearance of amyloid-{beta} (A{beta}) from the brain is essential for preventing neurodegenerative diseases such as Alzheimers. A significant portion of this clearance occurs through the blood-brain barrier (BBB) via receptor-mediated transport. However, current models fail to capture the complex kinetics and spatial heterogeneity of receptors at the BBB. In this study, we derive a novel boundary condition that accounts for finite receptor kinetics, receptor density, and bidirectional transport across the BBB. Specifically, we develop a nonlinear homogenized boundary condition that ensures mass conservation and incorporates receptor-mediated Michaelis-Menten kinetics. We then implement this boundary condition in a cylindrical geometry representing a capillary surrounded by brain tissue. After verifying that the model matches an analytical steady state solution that we derive and that it yields realistic blood A{beta} concentrations, we explore how realistic variations in parameter values drive changes in both steady state A{beta} concentration and transient dynamics. Simulations and analytical results reveal that A{beta} concentrations in the brain are sensitive to receptor number ratios, while concentrations in the blood are primarily affected by the blood clearance rate. Additionally, we use the model to investigate A{beta} clearance during sequential sleep cycles and due to a pathological phenomenon, spreading depolarization. This work presents the first biophysically consistent boundary condition for A{beta} transport across the BBB, offering a powerful tool for studying brain waste clearance under both physiological and pathological conditions.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amyloid-beta peptides 40 and 42 employ distinct molecular pathways for cell entry and intracellular transit at the BBB endothelium
Zengtao Wang, Nidhi Sharda, … Karunya K. Kandimalla·bioRxiv·Nov 17, 2022
- Multivalent Targeting of Blood-Brain Barrier LRP1 for Neurovascular Recovery Therapy for Alzheimer s Disease
Junyang Chen, Pan Xiang, … Giuseppe Battaglia·bioRxiv·May 6, 2024
- Butyrate regulates the blood-brain barrier transport and intra-endothelial accumulation of Alzheimers disease Amyloid-beta peptides
Vaishnavi Veerareddy, Zengtao Wang, … Karunya K. Kandimalla·Molecular PharmaceuticsPeer-reviewed·May 21, 2026
- Quantitative Modelling of Amyloid-β Dynamics in Brain, CSF, and Plasma During Sleep and Wakefulness
Satyam Sangeet, Craig L. Phillips, … Svetlana Postnova·bioRxiv·Sep 14, 2026
- Numerical modeling of senile plaque development under conditions of limited diffusivity of amyloid-β monomers
A. V. Kuznetsov·bioRxiv·Jan 9, 2024
- The role of syndapin-2 mediated transcytosis across the blood-brain barrier on amyloid-beta accumulation in the brain
Diana M. Leite, Mohsen Seifi, … Giuseppe Battaglia·bioRxiv·Jul 12, 2020